United States, Sept. 30 -- The U.S. Food and Drug Administration conditionally approved Dectomax-CA1 (doramectin injection) injectable solution for the prevention and treatment of New World screwworm larval infestations, and prevention of NWS reinfestation for 21 days. Dectomax-CA1 is conditionally approved for use only in cattle. Dectomax-CA1 is eligible for conditional approval because it is intended to prevent and treat a serious or life-threatening disease in cattle, it addresses an unmet animal health need, and demonstrating effectiveness of the drug would require complex or particularly difficult studies. Dectomax is already fully approved under a New Animal Drug Application for treatment and control of certain nematode and arthropod ...